Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Label Mixup; SERTRALINE HCL Tablet, 50 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsule, 10 mg, NDC 00093081001, Pedigree: AD70585_4, EXP: 5/29/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003574, EXP: 6/24/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD46300_17, EXP: 5/15/2014; CHOLECALCIFEROL, Tablet,
| Distributed by / for | AidaPak Service, LLC |
| NDC | 16714061204 |
| Full product label | SERTRALINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714061204 |
| Recalling firm | Aidapak Services, LLC |
| Distribution | Repacked drugs were distributed in Arizona, California, Oregon, and Washington. |
| Quantity | 500 Tablets |
| Recall initiated | 2013-07-02 |
| Report date | 2014-01-22 |
| Recall completed | 2014-02-07 |
| Recall number | D-523-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Vancouver WA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗